Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Ivax OTCs, vitamins could get boosted distribution under merger with Bergen Brunswig.

This article was originally published in The Tan Sheet

Executive Summary

IVAX OTCs, VITAMINS COULD GET BOOSTED DISTRIBUTION THROUGH BERGEN MERGER: Ivax products from the company's Major Pharmaceuticals subsidiary, acquired in September 1995, consist of a line of 2,500 vitamins, OTCs and prescription products. Bergen has more than 16,000 managed care, retail chain and independent drug store customers. The proposed merger of Bergen Brunswig and Ivax was announced Nov. 11 by the Orange, Calif. wholesaler and the Miami, Fla. drug firm.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086356

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel